T. Rowe Price Investment Management
DH icon

T. Rowe Price Investment Management’s Definitive Healthcare DH Stock Holding History

T. Rowe Price Investment Management’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,286,425
Closed -$14.1M – 552
2022
Q4 		$14.1M Buy
1,286,425
+17,474
+1% +$225K 0.01% 489
2022
Q3 		$19.7M Buy
+1,268,951
New +$27.9M 0.02% 451

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Investment Management's DH Position: Q1 2023 in Review

T. Rowe Price Investment Management sold out of Definitive Healthcare (DH) in Q1 2023, closing a stake of 1,286,425 shares — an estimated $14.1M sold.

T. Rowe Price Investment Management first reported a position in DH in Q3 2022 and held it in 2 quarters. The position peaked at $19.7M in Q3 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2023.

  • T. Rowe Price Investment Management reported no remaining Definitive Healthcare position as of Q1 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,286,425 Definitive Healthcare shares in Q1 2023, an estimated $14.1M.
  • T. Rowe Price Investment Management first reported a position in Definitive Healthcare in Q3 2022 and held it in 2 quarters.
  • T. Rowe Price Investment Management's Definitive Healthcare position peaked at $19.7M in Q3 2022.
  • 144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2023, filed 15 May 2023.